About Us

About Us

One of the principal missions of the Macular Degeneration Association that distinguishes us from other Macular organizations is our focus on patient education that enables macular patients and their caregivers to live fuller and more comfortable lives with macular degeneration. Our seminars and conferences offer life-changing tools and knowledge for persons affected by macular degeneration.

About the Macular Degeneration Association

The Macular Degeneration Association is a nonprofit health organization providing macular research, information and advocacy. MDA is an IRS recognized 501(c)3 organization and contributions are tax-deductible to the extent permitted by law.

The Macular Degeneration Association (MDA) is a nonprofit health organization dedicated to educating and empowering age-related macular degeneration patients all across the world.

Age-related macular degeneration is an increasingly prevalent degenerative eye disease, affecting millions of aging seniors.  The mission of MDA is to educate patients on the latest advances in treating age-related macular degeneration (AMD).  However, our focus extends far beyond diagnosed patients. We are committed to the senior population at large, those most at risk of developing macular degeneration.

Our goal is to provide information about risk factors, genetic predisposition, and proper diagnosis, as well as preventative efforts and treatment options that will likely reduce the most adverse effect of AMD, blindness.

MDA is passionate about funding and developing sophisticated patient education and advocacy programs designed to improve macular patients’ quality of life.  This is accomplished through the Association’s patient education conferences and seminars held nationwide.

The Association honors its commitment to prioritizing patient education by aligning itself with experts in the macular field, investigating retina-related scientific breakthroughs, and disseminating new scientific advances to macular patients across the world.

We strongly believe that providing support, education and empowerment to the millions of people living with age-related macular degeneration will improve patient quality of life, and energize the retina field to develop advances in treating AMD.  It is our hope that encouraging knowledge and awareness will ultimately lead to a cure.